Erratum: lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma.


Journal

Oncology letters
ISSN: 1792-1082
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Oct 2021
Historique:
entrez: 30 8 2021
pubmed: 31 8 2021
medline: 31 8 2021
Statut: ppublish

Résumé

[This corrects the article DOI: 10.3892/ol.2021.12716.].

Identifiants

pubmed: 34457053
doi: 10.3892/ol.2021.12959
pii: OL-0-0-12959
pmc: PMC8358600
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

698

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright: © Yamada et al.

Auteurs

Classifications MeSH